Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ShareHope Medicine Co has the GF Score of 70, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes ShareHope Medicine Co
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
ShareHope Medicine Co (ROCO:8403) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
ShareHope Medicine Co GF Score Related Terms
ROCO:8403 vs MCK, COR, CAH: GF Score Comparison
For the Medical Distribution subindustry, ShareHope Medicine Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ShareHope Medicine Co GF Score vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ShareHope Medicine Co's GF Score distribution charts can be found below:
* The bar in red indicates where ShareHope Medicine Co's GF Score falls into.
ShareHope Medicine Co (ROCO:8403) has a GF Score of 70 as of Aug. 03, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on ShareHope Medicine Co and its competitors. This is 19% below median its historical median of 86.00. Over the past decade, ShareHope Medicine Co's GF Score has ranged from 33.00 to 94.00.
Is ShareHope Medicine Co's GF Score too high?
ShareHope Medicine Co's current GF Score of 70 is 19% below median its 10-year median of 86.00. Over the past 10 years, this metric has ranged from a low of 33.00 to a high of 94.00. Overall, ShareHope Medicine Co has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ShareHope Medicine Co's GF Score compare to MCK and COR?
ShareHope Medicine Co's GF Score of 70 can be compared against companies in the Medical Distribution industry. Historically, ShareHope Medicine Co's own GF Score has ranged from 33.00 to 94.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Distribution company?
A good GF Score depends on the Medical Distribution industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on ShareHope Medicine Co and its competitors. ShareHope Medicine Co's current GF Score is 70, which is 19% below median its own 10-year median of 86.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ShareHope Medicine Co stock overvalued right now?
Based on GuruFocus' analysis, ShareHope Medicine Co (ROCO:8403) is currently considered Possible Value Trap. The stock's GF Value™ is NT$29.89, compared to a current price of NT$18.95 — trading 36.6% below its estimated fair value. The current GF Score is 70, which is 19% below median its 10-year median of 86.00. ShareHope Medicine Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For ShareHope Medicine Co (ROCO:8403), the current GF Score is 70 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ShareHope Medicine Co (ROCO:8403) Overvalued in 2026?
Based on GuruFocus' analysis, ShareHope Medicine Co stock appears to be undervalued.
The current stock price of NT$18.95 is trading 36.6% below its estimated GF Value™ of NT$29.89.
GuruFocus considers ShareHope Medicine Co to be Possible Value Trap.
Key valuation signals for ROCO:8403:
GF Score: 70 (19% below median its 10-year median of 86.00)
GF Value™: NT$29.89 vs. price of NT$18.95 (36.6% below fair value)
No single metric tells the full story. See the ROCO:8403 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ShareHope Medicine Co Ltd is engaged in wholesale and retail sales of medicines and hygiene materials, leasing of assets for medical institutions to undertake related medical services, and physical examinations for Taiwanese people and foreign labors, on-site medical support services, hemodialysis business management, ophthalmic medical management, clothing-related management services, manufacturing, processing and sales of various non-woven fabrics and management consulting for chain pharmacies in collaboration with medical institutions.
70GF Score
Get the complete analysis for ROCO:8403
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:8403 has been successfully added to your 
